Cancer, a major world public health problem, is associated with chemotherapy treatments
whose administration leads to secondary concerns, such as oral mucositis (OM). The OM …

Oral mucositis is a common side-effect associated with conventional cancer therapy and has
also recently been reported in association with newly emerging cancer therapies. It is …

Radiotherapy, often with concomitant chemotherapy, has a significant role in the
management of head and neck cancer, however, radiotherapy induces adverse events …

Radiation-induced oral mucositis (RIOM) is one of the most frequent complications in head
and neck cancer (HNC) patients undergoing radiotherapy (RT). It is a type of mucosal injury …

Purpose The present retrospective multicenter study intended to investigate the factors
associated with severe oral mucositis and candidiasis in patients undergoing radiotherapy …

Oral mucositis is a common and most debilitating complication associated with cancer
therapy. Despite the significant clinical and economic impact of this condition, there is little to …

Background/purpose Radiotherapy for head and neck cancer often causes severe oral
mucositis. The purpose of this retrospective study was to further examine the risk factors for …

Low dose non-toxic disulfide cross-linked micelle (DCM) encapsulated paclitaxel (PTX) was
found to be highly efficacious as a radiosensitizer against oral cancer preclinical model …

Surgery is the current first choice for oral cancer treatment. Intensity-modulated radiation
therapy, molecular targeted drugs, and immune checkpoint inhibitors are still used as …

Purpose This retrospective study investigated the effect of perioperative oral care
intervention on postoperative outcomes in patients undergoing lung cancer resection, in …